BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 9121483)

  • 1. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene.
    Lefebvre V; Huang W; Harley VR; Goodfellow PN; de Crombrugghe B
    Mol Cell Biol; 1997 Apr; 17(4):2336-46. PubMed ID: 9121483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three high mobility group-like sequences within a 48-base pair enhancer of the Col2a1 gene are required for cartilage-specific expression in vivo.
    Zhou G; Lefebvre V; Zhang Z; Eberspaecher H; de Crombrugghe B
    J Biol Chem; 1998 Jun; 273(24):14989-97. PubMed ID: 9614106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue-specific enhancer.
    Bridgewater LC; Lefebvre V; de Crombrugghe B
    J Biol Chem; 1998 Jun; 273(24):14998-5006. PubMed ID: 9614107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway.
    Lefebvre V; Behringer RR; de Crombrugghe B
    Osteoarthritis Cartilage; 2001; 9 Suppl A():S69-75. PubMed ID: 11680692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward understanding SOX9 function in chondrocyte differentiation.
    Lefebvre V; de Crombrugghe B
    Matrix Biol; 1998 Mar; 16(9):529-40. PubMed ID: 9569122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional mechanisms of chondrocyte differentiation.
    de Crombrugghe B; Lefebvre V; Behringer RR; Bi W; Murakami S; Huang W
    Matrix Biol; 2000 Sep; 19(5):389-94. PubMed ID: 10980415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a new rat chondrosarcoma cell line to delineate a 119-base pair chondrocyte-specific enhancer element and to define active promoter segments in the mouse pro-alpha 1(II) collagen gene.
    Mukhopadhyay K; Lefebvre V; Zhou G; Garofalo S; Kimura JH; de Crombrugghe B
    J Biol Chem; 1995 Nov; 270(46):27711-9. PubMed ID: 7499238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9's ability to transactivate a Col2a1 chondrocyte-specific enhancer.
    Huang W; Zhou X; Lefebvre V; de Crombrugghe B
    Mol Cell Biol; 2000 Jun; 20(11):4149-58. PubMed ID: 10805756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional coactivator PGC-1alpha regulates chondrogenesis via association with Sox9.
    Kawakami Y; Tsuda M; Takahashi S; Taniguchi N; Esteban CR; Zemmyo M; Furumatsu T; Lotz M; Izpisúa Belmonte JC; Asahara H
    Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2414-9. PubMed ID: 15699338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer.
    Han Y; Lefebvre V
    Mol Cell Biol; 2008 Aug; 28(16):4999-5013. PubMed ID: 18559420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX9 exerts a bifunctional effect on type II collagen gene (COL2A1) expression in chondrocytes depending on the differentiation state.
    Kypriotou M; Fossard-Demoor M; Chadjichristos C; Ghayor C; de Crombrugghe B; Pujol JP; Galéra P
    DNA Cell Biol; 2003 Feb; 22(2):119-29. PubMed ID: 12713737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted expression of SHH affects chondrocyte differentiation, growth plate organization, and Sox9 expression.
    Tavella S; Biticchi R; Schito A; Minina E; Di Martino D; Pagano A; Vortkamp A; Horton WA; Cancedda R; Garofalo S
    J Bone Miner Res; 2004 Oct; 19(10):1678-88. PubMed ID: 15355563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sox9 is required for cartilage formation.
    Bi W; Deng JM; Zhang Z; Behringer RR; de Crombrugghe B
    Nat Genet; 1999 May; 22(1):85-9. PubMed ID: 10319868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of the Sry-related factor SOX6 contributes to bone morphogenetic protein-2-induced chondroblastic differentiation of C3H10T1/2 cells.
    Fernández-Lloris R; Viñals F; López-Rovira T; Harley V; Bartrons R; Rosa JL; Ventura F
    Mol Endocrinol; 2003 Jul; 17(7):1332-43. PubMed ID: 12677004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A zinc finger transcription factor, alphaA-crystallin binding protein 1, is a negative regulator of the chondrocyte-specific enhancer of the alpha1(II) collagen gene.
    Tanaka K; Matsumoto Y; Nakatani F; Iwamoto Y; Yamada Y
    Mol Cell Biol; 2000 Jun; 20(12):4428-35. PubMed ID: 10825206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligonucleotide decoy mimicking alphaA-crystallin-binding protein 1 binding site on mouse Col2a1 enhancer stimulates transcription from the adjacent Col2a1 promoter in chondrogenic ATDC5 cell.
    Yamagiwa H; Yamada Y; Bolander ME; Sarkar G
    Mol Biotechnol; 2004 Sep; 28(1):1-8. PubMed ID: 15456958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOX9 governs differentiation stage-specific gene expression in growth plate chondrocytes via direct concomitant transactivation and repression.
    Leung VY; Gao B; Leung KK; Melhado IG; Wynn SL; Au TY; Dung NW; Lau JY; Mak AC; Chan D; Cheah KS
    PLoS Genet; 2011 Nov; 7(11):e1002356. PubMed ID: 22072985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOX9 directly regulates the type-II collagen gene.
    Bell DM; Leung KK; Wheatley SC; Ng LJ; Zhou S; Ling KW; Sham MH; Koopman P; Tam PP; Cheah KS
    Nat Genet; 1997 Jun; 16(2):174-8. PubMed ID: 9171829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjacent DNA sequences modulate Sox9 transcriptional activation at paired Sox sites in three chondrocyte-specific enhancer elements.
    Bridgewater LC; Walker MD; Miller GC; Ellison TA; Holsinger LD; Potter JL; Jackson TL; Chen RK; Winkel VL; Zhang Z; McKinney S; de Crombrugghe B
    Nucleic Acids Res; 2003 Mar; 31(5):1541-53. PubMed ID: 12595563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis.
    Zhao Q; Eberspaecher H; Lefebvre V; De Crombrugghe B
    Dev Dyn; 1997 Aug; 209(4):377-86. PubMed ID: 9264261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.